未登录 分享 收藏
分享 收藏
分享 收藏
Enteral Low-Dose Vitamin A Supplementation in Preterm or Low Birth Weight Infants to Prevent Morbidity and Mortality: a Systematic Review and Meta-analysis Manapurath, Rukman M.; Kumar, Mohan; Pathak, Barsha Gadapani; Chowdhury, Ranadip; Sinha, Bireshwar; Choudhary, Tarun; Chandola, Naro; Mazumdar, Sarmila; Bhandari, Nita; Upadhyay, Ravi Prakash 分享 收藏
分享 收藏
Enteral Multiple Micronutrient Supplementation in Preterm and Low Birth Weight Infants: A Systematic Review and Meta-analysis Kumar, Mohan; Chowdhury, Ranadip; Sinha, Bireshwar; Upadhyay, Ravi Prakash; Chandola, Temsunaro Rongsen; Mazumder, Sarmila; Taneja, Sunita; Edmond, Karen; Bahl, Rajiv; Bhandari, Nita; Ramakrishnan, Usha; Rivera, Juan A.; Tandon, Sonia; Duggan, Christopher P.; Liu, Enju; Fawzi, Wafaie; Manji, Karim; Choudhary, Tarun Shankar 分享 收藏
Enteral Vitamin D Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis Kumar, Mohan; Shaikh, Saijuddin; Sinha, Bireshwar; Upadhyay, Ravi Prakash; Choudhary, Tarun Shankar; Chandola, Temsunaro Rongsen; Mazumder, Sarmila; Taneja, Sunita; Bhandari, Nita; Chowdhury, Ranadip 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Incidence of lab-confirmed dengue fever in a pediatric cohort in Delhi, India Sinha, Bireshwar; Goyal, Nidhi; Kumar, Mohan; Choudhary, Aashish; Arya, Alok; Revi, Anitha; Dutta, Ankita; More, Deepak; Rongsen-Chandola, Temsunaro 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
QUALITY OF LIFE IN ADVANCED NON-SMALL CELL LUNG CANCER, EFFECTS OF CISPLATIN DOSE AND CARBOPLATIN IN COMBINATION WITH GEMCITABINE: RESULTS FROM BTOG2, A BRITISH THORACIC ONCOLOGY GROUP PHASE III TRIAL IN 1363 PATIENTS Billingham, L. J.; Gaunt, P.; Jarrett, H. W.; Dunlop, D.; Thompson, J.; O'Byrne, K. J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; Hill, M.; Ferry, D. 分享 收藏
BRITISH THORACIC ONCOLOGY GROUP TRIAL, BTOG2: RANDOMISED PHASE III CLINICAL TRIAL OF GEMCITABINE COMBINED WITH CISPLATIN 50 MG/M2 (GC50) VS CISPLATIN 80 MG/M2 (GC80) VS CARBOPLATIN AUC 6 (GCB6) IN ADVANCED NSCLC Ferry, D.; Billingham, L. J.; Jarrett, H. W.; Dunlop, D.; Thompson, J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; Hill, M.; Pirrie, S.; O'Byrne, K. J. 分享 收藏
DELIVERED DOSE INTENSITY OF GEMCITABINE 1250 MG/M2 WITH CISPLATIN AT 80 MG/M2 (GC80) AND 50 MG/M2 (GC50) AND CARBOPLATIN AUC 6 (GCB6) IN A PHASE III TRIAL OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): CORRELATIONS WITH CLINICAL OUTCOMES Dunlop, D.; Ferry, D.; Jarrett, H. W.; Billingham, L. J.; Thompson, J.; Kumar, M.; Skailes, G.; Nicolson, M.; Shah, R.; Leonard, P.; Chetiyawardana, A.; Wells, P.; Lewanski, C.; Woll, P.; Crosse, B.; O'Byrne, K. J. 分享 收藏
分享 收藏
分享 收藏